GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Diamyd Medical AB (FRA:DMN) » Definitions » Tax Rate %

Diamyd Medical AB (FRA:DMN) Tax Rate % : 0.00% (As of Nov. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Diamyd Medical AB Tax Rate %?

Tax Rate % is calculated as Tax Expense divided by its Pre-Tax Income. Diamyd Medical AB's Tax Expense for the three months ended in Nov. 2024 was €0.00 Mil. Diamyd Medical AB's Pre-Tax Income for the three months ended in Nov. 2024 was €-3.12 Mil. Therefore, Diamyd Medical AB's Tax Rate % for the quarter that ended in Nov. 2024 was 0.00%.

Diamyd Medical AB Tax Rate % Historical Data

The historical data trend for Diamyd Medical AB's Tax Rate % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diamyd Medical AB Tax Rate % Chart

Diamyd Medical AB Annual Data
Trend Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23 Aug24
Tax Rate %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Diamyd Medical AB Quarterly Data
Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24
Tax Rate % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Diamyd Medical AB Tax Rate % Calculation

Tax Rate % is the ratio of tax expense divided by pretax income, usually presented in percent.

Diamyd Medical AB's Tax Rate % for the fiscal year that ended in Aug. 2024 is calculated as

Tax Rate %=Tax Expense (A: Aug. 2024 )/Pre-Tax Income (A: Aug. 2024 )
=0/-13.256
=0.00 %

Diamyd Medical AB's Tax Rate % for the quarter that ended in Nov. 2024 is calculated as

Tax Rate %=Tax Expense (Q: Nov. 2024 )/Pre-Tax Income (Q: Nov. 2024 )
=0/-3.123
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Diamyd Medical AB Tax Rate % Related Terms

Thank you for viewing the detailed overview of Diamyd Medical AB's Tax Rate % provided by GuruFocus.com. Please click on the following links to see related term pages.

Diamyd Medical AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Diamyd Medical AB (FRA:DMN) » Definitions » Tax Rate %
Comparable Companies
OSTO:BINV OSTO:EGTX OSTO:HNSA OSTO:GENO OSTO:VICO OSTO:XSPRAY OSTO:SYNACT OSTO:SANION OSTO:IRLAB A OSTO:ABLI VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY ONC BNTX XKRX:068270
Traded in Other Exchanges
DMYD B:Sweden
Address
Kungsgatan 29, Stockholm, SWE, SE-111 56
Website
https://www.diamyd.com
Diamyd Medical AB is a Sweden-based company engaged in the field of pharmaceutical development. It develops therapies using in-licensed substances glutamic acid decarboxylase (GAD) and GABA for the prevention or treatment of diabetes and other inflammatory diseases. The firm is focused on finding the cure for diabetes and other serious inflammatory diseases through pharmaceutical development and investments in stem cells and medical technology. Its product portfolio consists of Diamyd, for the treatment of autoimmune diabetes; Remygen, a regenerative and immunomodulatory therapy for the treatment of autoimmune diabetes and type 2 and type 1 diabetes.